United States · FDA National Drug Code directory
BLIP
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82966-303_958a5fbc-b7ae-42da-a942-8f43655b10ba
- Product NDC
- 82966-303
- Form
- LOZENGE
- Composition / generic term
- Nicotine Polacrilex
- Labeler
- Blip Products, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250813
- Source listing expiry
- 20271231
Source-listed ingredients
- NICOTINE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 CONTAINER in 1 CARTON (82966-303-00) / 27 LOZENGE in 1 CONTAINER (82966-303-27) · 82966-303-00
- 4 CONTAINER in 1 CARTON (82966-303-10) / 27 LOZENGE in 1 CONTAINER (82966-303-27) · 82966-303-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →